Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541397 · ClinicalTrials.gov registry record · NA
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01541397: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT01541397 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01541397, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Prospective study to compare the bone mineral density in adults with HPA on KUVAN™ therapy to those not on therapy. The investigators hypothesize that after one year of KUVAN™ therapy, there will be an improvement in their bone mineral density.
Primary Outcome
A DXA scan will be conducted one year after Kuvan therapy is initiated.
Interventions
- DRUG Sapropterin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-08 |
| Phase | NA |
Why NCT01541397 stopped before completion
NCT01541397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Sapropterin is the first listed.
NCT01541397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01541397 about?
NCT01541397 is a clinical study titled "Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy". Prospective study to compare the bone mineral density in adults with HPA on KUVAN™ therapy to those not on therapy. The investigators hypothesize that after one year of KUVAN™ therapy, there will be an improvement in their bone mineral density.
What is the current status of trial NCT01541397?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2011-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01541397?
The interventions under investigation include: Sapropterin (DRUG).
Who is sponsoring clinical trial NCT01541397?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01541397's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia